Citigroup Lowers Health Catalyst (NASDAQ:HCAT) Price Target to $2.00

by · The Cerbat Gem

Health Catalyst (NASDAQ:HCAT – Get Free Report) had its price target decreased by equities research analysts at Citigroup from $2.50 to $2.00 in a note issued to investors on Tuesday,Benzinga reports. The firm presently has a “neutral” rating on the stock. Citigroup’s price target points to a potential upside of 12.04% from the stock’s previous close.

Several other analysts have also recently commented on HCAT. Weiss Ratings raised Health Catalyst from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Tuesday, July 28th. Canaccord Genuity Group raised their price objective on Health Catalyst from $2.00 to $3.00 and gave the stock a “buy” rating in a research report on Tuesday, July 21st. Cantor Fitzgerald reaffirmed a “neutral” rating on shares of Health Catalyst in a research note on Monday, May 11th. Stephens reduced their price target on shares of Health Catalyst from $2.00 to $1.75 and set an “equal weight” rating for the company in a research report on Tuesday, May 12th. Finally, Wells Fargo & Company increased their target price on shares of Health Catalyst from $1.00 to $1.75 and gave the stock an “equal weight” rating in a research report on Friday, June 26th. Four research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $2.95.

Get Our Latest Report on Health Catalyst

Health Catalyst Trading Up 3.8%

Shares of Health Catalyst stock traded up $0.07 during trading on Tuesday, hitting $1.78. The stock had a trading volume of 1,920,062 shares, compared to its average volume of 1,116,998. Health Catalyst has a 1 year low of $0.96 and a 1 year high of $3.80. The stock has a 50 day simple moving average of $1.99 and a 200 day simple moving average of $1.70. The company has a quick ratio of 1.69, a current ratio of 1.69 and a debt-to-equity ratio of 1.10. The company has a market capitalization of $134.34 million, a PE ratio of -0.49 and a beta of 1.55.

Health Catalyst (NASDAQ:HCAT – Get Free Report) last posted its quarterly earnings data on Thursday, August 6th. The company reported $0.04 EPS for the quarter, topping analysts’ consensus estimates of $0.03 by $0.01. Health Catalyst had a negative net margin of 90.61% and a negative return on equity of 1.57%. The firm had revenue of $70.49 million during the quarter, compared to analyst estimates of $69.09 million. On average, research analysts expect that Health Catalyst will post -0.25 EPS for the current fiscal year.

Institutional Investors Weigh In On Health Catalyst

Hedge funds and other institutional investors have recently made changes to their positions in the company. nVerses Capital LLC acquired a new stake in shares of Health Catalyst during the 4th quarter valued at about $25,000. Cresset Asset Management LLC acquired a new position in Health Catalyst in the second quarter worth approximately $39,000. Deutsche Bank AG bought a new position in Health Catalyst during the second quarter valued at approximately $43,000. Focus Partners Wealth acquired a new stake in Health Catalyst in the first quarter valued at approximately $46,000. Finally, BNP Paribas Financial Markets increased its stake in shares of Health Catalyst by 71.7% during the 3rd quarter. BNP Paribas Financial Markets now owns 16,355 shares of the company’s stock worth $47,000 after purchasing an additional 6,832 shares during the last quarter. 85.00% of the stock is owned by hedge funds and other institutional investors.

Health Catalyst Company Profile

(Get Free Report)

Health Catalyst (NASDAQ: HCAT) is a healthcare data and analytics technology company founded in 2008 and headquartered in Salt Lake City, Utah. The company went public in 2019 and has since focused on delivering a unified data platform that helps healthcare organizations aggregate and analyze clinical, financial and operational information.

The core of Health Catalyst’s offering is the Data Operating System (DOS), a modular data management platform that integrates disparate data sources—from electronic health records to claims and patient-generated data—into a single analytics environment.

Further Reading